Connecticut House Bill 5366 (Prior Session Legislation)

---

Spectrum: Bipartisan Bill
Status: Introduced on February 27 2020 - 25% progression, died in chamber
Action: 2020-03-11 - Filed with Legislative Commissioners' Office
Text: Latest bill text (Introduced) [PDF]

To: (1) Cap aggregate monthly cost-sharing for prescription drugs covered under certain individual and group health insurance policies; (2) cap the cost of generic drugs in this state; (3) require the Commissioner of Consumer Protection to submit a request to the federal Secretary of Health and Human Services to implement a Canadian prescription drug reimportation program in this state and, if the secretary approves such request, implement such program in this state; (4) require pharmaceutical manufacturers to send notice to the Insurance Commissioner regarding "pay-for-delay" agreements, and require health carriers and pharmacy benefits managers to reduce the cost of brand name prescription drugs that are the subject of such agreements; (5) establish a Critical Drug Shortage Review Board; and (6) limit the circumstances in which a health carrier may remove a prescription drug from a drug formulary or list of covered drugs, or move a prescription drug to a different cost-sharing tier, during a plan year.

An Act Concerning The Cost Of Prescription Drugs.

House Insurance and Real Estate Committee

Sen. Saud Anwar [D]

2020-03-11 - Joint - INS Vote Tally Sheet (Joint Favorable Substitute) (Y: 15 N: 4 NV: 0 Abs: 1) [PASS]

Date	Chamber	Action
2020-03-11	House	Filed with Legislative Commissioners' Office
2020-03-10	House	Joint Favorable Substitute
2020-02-28	House	Public Hearing 03/03
2020-02-27	House	Referred to Joint Committee on Insurance and Real Estate

Type	Source
Summary	https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=HB05366&which_year=2020
Text	https://www.cga.ct.gov/2020/TOB/h/pdf/2020HB-05366-R00-HB.PDF
Roll Call	https://www.cga.ct.gov/2020/TS/h/pdf/2020HB-05366-R00INS-CV9-TS.pdf